@inproceedings{inproceedings, title  = {{437 Treatment-emergent adverse events in patients aged 6 months to 5 years with moderate-to-severe atopic dermatitis treated with dupilumab in an open-label extension clinical trial}},

 publisher = {{Oxford University Press (OUP)}},

 url = {{http://dx.doi.org/10.1093/bjd/ljad162.057 }},

 year = {{2023}},

 month = {{6}},

 author = {{Paller AS and Siegfried EC and Sidbury R and Lockshin B and Cork M and Pinter A and Xiao J and Khokhar FA and Bansal A and Prescilla R}},

 doi = {{10.1093/bjd/ljad162.057}},

 volume = {{188}},

 journal = {{British Journal of Dermatology}},

 issue = {{Supplement_3}},

 note = {{Accessed on 2024/12/22}}}